Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by Healthnews referenced an article published on AJMC.com, the website of The American Journal of Managed Care®. The article, “Noninvasive Blood Glucose Measurement Methods Demonstrate Potential in Diabetes,” explained how the promising results from noninvasive methods of measuring blood glucose could point to potential replacements for measurement and monitoring in the future.
The National Pharmaceutical Council’s CER Daily Newsfeed for March 23, 2023, featured 2 articles and a video published on AJMC.com. The articles were titled “Experts Call for a More Patient-Focused Approach to Prior Authorization” and “Building Better Equity-Based Benefit Designs,” and the video was titled “Dr Ben Urick Explains Challenges With Current Literature Linking Medication Adherence to Medical Cost Offsets.”
House lawmakers are expected to advance a contracting ban today on 5 Chinese research firms; US government officials temporarily relaxed strict guidelines on how laboratories handle, store, and transport H5N1 bird flu samples; a recent report found that the number of abortions occurring in the US continued to grow despite bans.
Read More
Patients With MG Report Higher Azathioprine Discontinuation vs Other Immunosuppressants
May 15th 2024Survey data from over 200 patients showed that treatment discontinuation was lower for those taking mycophenolate or methotrexate than for those taking azathioprine for their myasthenia gravis (MG).
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study
May 15th 2024This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.
Read More
Valoctocogene Roxaparvovec Dramatically Reduces Bleeding in Hemophilia A
May 15th 2024New study findings demonstrate that valoctocogene roxaparvovec, a gene therapy for severe hemophilia A, significantly reduces bleeding episodes and dependency on factor VIII infusions over a 3-year period, while maintaining a favorable safety profile.
Read More